Middle East Journal of Cancer

Shiraz University of Medical Sciences

Journal websitePeer review: Double-blind review
Evaluation status available after sign-in

About the journal

Middle East Journal of Cancer is an open-access journal published by Shiraz University of Medical Sciences in Iran, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 9,000,000 IRR. Declared review time at DOAJ: 14 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Shiraz University of Medical Sciences
ISSN
2008-6709 · 2008-6687
Country
Iran
Languages
english
Access
Open access
Declared publication charge
9,000,000 IRR
Articles in DOAJ
775
Declared review time
14 weeks
Declared peer-review model
double_blind
Official website
http://mejc.sums.ac.ir

Index listings

  • DOAJ · 2010-10-19
Indexing
DOAJ
APC
9,000,000 IRR
Declared review time (DOAJ)
14 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Dormant — no works recorded since 2018
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

775

Most recent article

2 months ago

Average review time (journal-declared via DOAJ)

14weeks

Works in OpenAlex

55

Last recorded publication year

2021

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

7

i10-index

6

From OpenAlex open data (CC0).

Editorial & policy6
Last DOAJ review date
2022-02-13
Added to DOAJ
2010-10-19
Declared plagiarism screening
Declared
Other fees beyond APC
Yes
Editorial board
Official page ↗
Peer-review policy
View policy
Identity & continuity2
Alternate titles
MEJC
Source type
journal
Classification2

Subjects (DOAJ)

Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens

LCC codes

RC254-282

Subject areas

  • Head and Neck Cancer Studies
  • Head and Neck Cancer Studies
  • Cancer Diagnosis and Treatment
  • Cancer Diagnosis and Treatment
  • Advanced Radiotherapy Techniques
  • Advanced Radiotherapy Techniques
  • Radiation Dose and Imaging
  • Neurofibromatosis and Schwannoma Cases
Show all subjects (50)
  • Head and Neck Surgical Oncology
  • Management of metastatic bone disease
  • Glioma Diagnosis and Treatment
  • Breast Cancer Treatment Studies
  • Lymphoma Diagnosis and Treatment
  • Sarcoma Diagnosis and Treatment
  • Bladder and Urothelial Cancer Treatments
  • Global Cancer Incidence and Screening
  • HER2/EGFR in Cancer Research
  • Breast Cancer Treatment Studies
  • Management of metastatic bone disease
  • Head and Neck Surgical Oncology
  • Neurofibromatosis and Schwannoma Cases
  • Radiation Dose and Imaging
  • HER2/EGFR in Cancer Research
  • Global Cancer Incidence and Screening
  • Bladder and Urothelial Cancer Treatments
  • Sarcoma Diagnosis and Treatment
  • Lymphoma Diagnosis and Treatment
  • Glioma Diagnosis and Treatment
  • Cancer and Skin Lesions
  • Urological Disorders and Treatments
  • Cancer Treatment and Pharmacology
  • Brain Metastases and Treatment
  • Meningioma and schwannoma management
  • Breast Lesions and Carcinomas
  • Salivary Gland Tumors Diagnosis and Treatment
  • Colorectal Cancer Screening and Detection
  • Ovarian cancer diagnosis and treatment
  • Oral and Maxillofacial Pathology
  • Ovarian cancer diagnosis and treatment
  • Cancer and Skin Lesions
  • Urological Disorders and Treatments
  • Salivary Gland Tumors Diagnosis and Treatment
  • Breast Lesions and Carcinomas
  • Meningioma and schwannoma management
  • Brain Metastases and Treatment
  • Cancer Treatment and Pharmacology
  • Oral and Maxillofacial Pathology
  • Health Systems, Economic Evaluations, Quality of Life
  • Health Systems, Economic Evaluations, Quality of Life
  • Colorectal Cancer Screening and Detection

Keywords (DOAJ)

  • cancer immunology
  • cancer epidemiology
  • cancer treatment
  • cancer rehabilitation
  • cancer palliative care

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: